Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

Search for boehringer ingelheim in registrations and monthly communication reports

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (84)
Results: 1-50 | Export
  1. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 14 of 14 (2024-01-09 to present)
    Posted: 2024-01-09
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  2. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 8 of 8 (2024-01-08 to present)
    Posted: 2024-01-09
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  3. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 13 of 14 (2024-01-08 to 2024-01-09)
    Posted: 2024-01-09
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  4. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 12 of 14 (2023-12-20 to 2024-01-08)
    Posted: 2023-12-21
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  5. Boehringer Ingelheim (Canada) Ltd.
    Type: Consultant
    Lobbyist: Lily Mesh, Wellington Dupont Public Affairs
    Registration: 3 of 3 (2023-09-01 to present)
    Posted: 2023-09-06
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  6. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Responsible officer: Mark Lewis, President and CEO
    Registration: 4 of 4 (2023-08-15 to present)
    Posted: 2023-09-06
    Subject matter details: 2
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  7. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Registration: 6 of 6 (2023-06-27 to present)
    Posted: 2023-09-18
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  8. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Responsible officer: Ruta Stauskas, VP, Human Resources
    Registration: 3 of 4 (2023-06-01 to 2023-08-15)
    Posted: 2023-06-16
    Subject matter details: 2
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  9. Boehringer Ingelheim (Canada) Ltd.
    Type: Consultant
    Lobbyist: Emily-Jean Gallant, Wellington Dupont Public Affairs
    Registration: 1 of 1 (2023-05-18 to present)
    Posted: 2023-05-18
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  10. Boehringer Ingelheim (Canada) Ltd.
    Type: Consultant
    Lobbyist: Justine Yeong, Wellington Dupont Public Affairs
    Registration: 1 of 1 (2023-05-18 to present)
    Posted: 2023-05-18
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  11. Boehringer Ingelheim (Canada) Ltd.
    Type: Consultant
    Lobbyist: Summer Senter, Wellington-Dupont Public Affairs
    Registration: 3 of 3 (2023-05-17 to 2023-11-16)
    Posted: 2023-05-17
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  12. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Registration: 5 of 6 (2023-04-01 to 2023-06-27)
    Posted: 2023-04-03
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  13. Boehringer Ingelheim (Canada) Ltd.
    Type: Consultant
    Lobbyist: Hoda Almoflehi, Wellington Dupont Public Affairs
    Registration: 1 of 1 (2023-03-09 to 2023-09-16)
    Posted: 2023-03-13
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  14. Boehringer Ingelheim (Canada) Ltd.
    Type: Consultant
    Lobbyist: Lily Mesh, Wellington Dupont Public Affairs
    Registration: 2 of 3 (2023-01-18 to 2023-07-16)
    Posted: 2023-01-25
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  15. Boehringer Ingelheim (Canada) Ltd.
    Type: Consultant
    Lobbyist: Summer Senter, Wellington-Dupont Public Affairs
    Registration: 2 of 3 (2022-11-21 to 2023-05-16)
    Posted: 2022-11-22
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  16. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 11 of 14 (2022-11-14 to 2023-12-20)
    Posted: 2022-11-17
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  17. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Johanne Chambers, 3Sixty Public Affairs Inc.
    Registration: 8 of 8 (2022-11-14 to 2023-09-15)
    Posted: 2022-11-17
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  18. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 7 of 8 (2022-11-14 to 2024-01-08)
    Posted: 2022-11-17
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  19. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Johanne Chambers, 3Sixty Public Affairs Inc.
    Registration: 7 of 8 (2022-10-14 to 2022-11-14)
    Posted: 2022-10-17
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  20. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Registration: 4 of 6 (2022-10-11 to 2023-04-01)
    Posted: 2022-10-13
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  21. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Responsible officer: Andrea Sambati, President, CEO
    Registration: 2 of 4 (2022-06-24 to 2023-06-01)
    Posted: 2023-01-13
    Subject matter details: 2
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  22. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Responsible officer: Andrea Sambati, President, CEO
    Registration: 1 of 4 (2022-05-30 to 2022-06-24)
    Posted: 2022-06-01
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  23. Boehringer Ingelheim (Canada) Ltd.
    Type: Consultant
    Lobbyist: Summer Senter, Wellington-Dupont Public Affairs
    Registration: 1 of 3 (2022-05-16 to 2022-11-16)
    Posted: 2022-05-17
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  24. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Johanne Chambers, 3Sixty Public Affairs Inc.
    Registration: 6 of 8 (2022-05-16 to 2022-10-14)
    Posted: 2022-05-17
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  25. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 10 of 14 (2022-04-22 to 2022-11-14)
    Posted: 2022-04-25
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  26. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 6 of 8 (2022-04-22 to 2022-11-14)
    Posted: 2022-04-25
    Subject matter details: 9
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  27. Resilient Healthcare Coalition
    Type: Consultant
    Lobbyist: Izabella Kaczmarek, Santis Health
    Registration: 2 of 2 (2022-03-21 to 2022-07-12)
    Posted: 2022-03-21
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
  28. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 5 of 8 (2022-02-28 to 2022-04-22)
    Posted: 2022-02-28
    Subject matter details: 9
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  29. Boehringer Ingelheim (Canada) Ltd.
    Type: Consultant
    Lobbyist: Lily Mesh, Wellington Dupont Public Affairs
    Registration: 1 of 3 (2022-01-17 to 2023-01-17)
    Posted: 2022-01-25
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  30. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: Summer Senter, Wellington-Dupont Public Affairs
    Registration: 2 of 2 (2020-11-26 to 2021-05-16)
    Posted: 2020-11-26
    Subject matter details: 3
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
  31. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: Emily Keller, Wellington Dupont Public Affairs
    Registration: 1 of 1 (2020-09-29 to 2021-01-04)
    Posted: 2020-09-30
    Subject matter details: 3
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
  32. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: Matthew Henley, Wellington Dupont
    Registration: 4 of 4 (2019-07-19 to 2020-11-23)
    Posted: 2019-07-29
    Subject matter details: 3
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
  33. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: Summer Senter, Wellington-Dupont Public Affairs
    Registration: 1 of 2 (2019-07-15 to 2020-07-16)
    Posted: 2019-07-18
    Subject matter details: 3
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
  34. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: Matthew Henley, Wellington Dupont
    Registration: 3 of 4 (2019-04-25 to 2019-07-19)
    Posted: 2019-04-26
    Subject matter details: 3
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
  35. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: Scott Gorry, Wellington-Dupont Public Affairs
    Registration: 1 of 1 (2018-07-31 to 2019-02-16)
    Posted: 2018-08-02
    Subject matter details: 3
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  36. Life Sciences Ontario (LSO)
    Type: Consultant
    Lobbyist: Muhammad Ali, Hill+Knowlton Strategies / Hill+Knowlton Stratégies
    Registration: 2 of 2 (2018-07-10 to 2019-02-15)
    Posted: 2018-07-10
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  37. Life Sciences Ontario (LSO)
    Type: Consultant
    Lobbyist: Muhammad Ali, Hill+Knowlton Strategies / Hill+Knowlton Stratégies
    Registration: 1 of 2 (2018-01-11 to 2018-06-15)
    Posted: 2018-01-12
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  38. Life Sciences Ontario (LSO)
    Type: Consultant
    Lobbyist: Omar Khan, Hill+Knowlton Strategies
    Registration: 1 of 1 (2018-01-05 to 2018-07-17)
    Posted: 2018-01-12
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  39. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: Matthew Henley, Wellington Dupont
    Registration: 2 of 4 (2017-10-26 to 2019-04-25)
    Posted: 2017-10-27
    Subject matter details: 3
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
  40. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: Matthew Henley, Wellington Dupont
    Registration: 1 of 4 (2017-10-02 to 2017-10-26)
    Posted: 2017-10-19
    Subject matter details: 1
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  41. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 1 of 5 (2016-11-22 to 2017-06-04)
    Posted: 2016-12-07
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  42. Boehringer Ingelheim (Canada) Ltd
    Type: Consultant
    Lobbyist: Hal Danchilla, Canadian Strategy Group
    Registration: 2 of 2 (2016-06-16 to 2016-11-14)
    Posted: 2016-06-21
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  43. Boehringer Ingelheim (Canada) Ltd
    Type: Consultant
    Lobbyist: Hal Danchilla, Canadian Strategy Group
    Registration: 1 of 2 (2013-06-05 to 2016-06-16)
    Posted: 2013-06-06
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  44. Boehringer Ingelheim (Canada) Ltd.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 1 (2011-01-14 to 2011-03-01)
    Posted: 2011-01-28
    Subject matter details: 10
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  45. Boehringer Ingelheim (Canada) Ltd.
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 1 (2011-01-14 to 2011-08-26)
    Posted: 2011-01-28
    Subject matter details: 10
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  46. BOEHRINGER INGELHEIM (CANADA) LTD.
    Type: Consultant
    Lobbyist: SARA NEAMTZ, Fleishman-Hillard Canada Inc.
    Registration: 3 of 3 (2007-07-27 to 2007-08-09)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
  47. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: MICHAEL VON HERFF, Fleishman-Hillard Canada Inc.
    Registration: 3 of 3 (2007-07-26 to 2007-08-09)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  48. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: AGNES CHAUDRON, Fleishman-Hillard Canada Inc
    Registration: 3 of 3 (2007-07-25 to 2008-01-14)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  49. BOEHRINGER INGELHEIM
    Type: Consultant
    Lobbyist: Kevin Macintosh, Fleishman-Hillard Canada Inc
    Registration: 2 of 2 (2007-02-07 to 2007-07-03)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  50. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: AGNES CHAUDRON, Fleishman-Hillard Canada Inc
    Registration: 2 of 3 (2007-02-07 to 2007-07-25)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No

Monthly communication reports (18)
Results: 1-18 | Export
  1. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2023-10-04
    Posted: 2023-11-15
    Designated public office holders:
    • Joanna Lam, Policy and Regional Affairs Advisor | Indigenous Services Canada (ISC)
    Subject matters:
    • Health
  2. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2023-08-03
    Posted: 2023-09-15
    Designated public office holders:
    • Dr. Stephen Ellis, MP | House of Commons
    Subject matters:
    • Health
  3. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2023-06-29
    Posted: 2023-08-14
    Designated public office holders:
    • Daniel Saad, Senior Policy Advisor, Policy and Cabinet Affairs | Prime Minister's Office (PMO)
    Subject matters:
    • Health
  4. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2023-05-17
    Posted: 2023-06-15
    Designated public office holders:
    • Daniel macdonald, Director General, Drugs for Rare Diseases | Health Canada (HC)
    Subject matters:
    • Health
  5. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2023-03-10
    Posted: 2023-04-15
    Designated public office holders:
    • Kasondra White, Director, Biomanufacturing Branch, Strategy Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General, Life Sciences and Biomanufacturing Branch | Innovation, Science and Economic Development Canada (ISED)
    • Eric Costen , Senior ADM, Industry Sector | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
  6. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2022-12-06
    Posted: 2023-01-13
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Daniel MacDonald, Director General, Drugs for Rare Diseases | Health Canada (HC)
    • Michelle Mujoomdar, Director, Specialty Pharmaceuticals | Health Canada (HC)
    Subject matters:
    • Health
  7. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2022-10-05
    Posted: 2022-10-12
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Mujoomdar, Director, Specialty Pharmaceuticals | Health Canada (HC)
    Subject matters:
    • Health
  8. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2022-10-03
    Posted: 2022-10-12
    Designated public office holders:
    • Zachary Nixon, Senior Assistant, Stakeholder Relations & Regional Affairs | Global Affairs Canada (GAC)
    Subject matters:
    • Health
  9. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2022-09-13
    Posted: 2022-09-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Zachary Nixon, Senior Special Assistant Stakeholder Relations and Regional Affairs | Global Affairs Canada (GAC)
    Subject matters:
    • Health
  10. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2022-07-15
    Posted: 2022-08-04
    Designated public office holders:
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
  11. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2022-07-11
    Posted: 2022-08-04
    Designated public office holders:
    • Adam Van Koeverden, Member of Parliament | House of Commons
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
  12. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2022-07-11
    Posted: 2022-08-04
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
  13. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2022-05-31
    Posted: 2022-06-28
    Designated public office holders:
    • Adam Van Koeverden, Member of Parliament | House of Commons
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
  14. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2022-05-30
    Posted: 2022-06-28
    Designated public office holders:
    • Ed Fast, Member of Parliament | House of Commons
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
  15. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: Matthew Henley, Wellington Dupont
    Occurred: 2017-11-23
    Posted: 2017-12-14
    Designated public office holders:
    • Ron McKinnon, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Aboriginal Affairs
    • Research and Development
    • Economic Development
    • Science and Technology
    • Health
    • Budget
  16. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: Matthew Henley, Wellington Dupont
    Occurred: 2017-11-23
    Posted: 2017-12-15
    Designated public office holders:
    • Earl Dreeshen, Member of Parliament | House of Commons
    Subject matters:
    • Budget
    • Economic Development
    • Industry
    • Aboriginal Affairs
    • International Trade
    • Science and Technology
    • Research and Development
    • Health
  17. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: Matthew Henley, Wellington Dupont
    Occurred: 2017-11-23
    Posted: 2017-12-15
    Designated public office holders:
    • Parvinder Sachdeva, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • Hilary Travis, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Aboriginal Affairs
    • Industry
    • Science and Technology
    • Budget
    • Taxation and Finance
    • Research and Development
  18. Boehringer Ingelheim
    Type: Consultant
    Lobbyist: Matthew Henley, Wellington Dupont
    Occurred: 2017-11-22
    Posted: 2017-12-15
    Designated public office holders:
    • Kyle McKenzie, Sr Policy Advisor | Indigenous and Northern Affairs Canada
    Subject matters:
    • Aboriginal Affairs
    • Research and Development
    • Health
    • Science and Technology

Date Modified: